Oncolytics Biotech investment thesis

 Free stock research blog. Invest at your own risk.

www.oncolyticsbiotech.com  ONCY NASDAQ 

ONC.TO   Currently  1.31$ US 1.71 CDN

I could write a 500 page book on why I think Oncolytics Biotech is a good stock to buy but the Focus of this investment Blog is to keep things simple.  With a Title and 5 main Points to buy each of our 5 stocks that we think have potential to double in value.

Pancreatic Cancer,  Pancreatic Cancer, 

 Pancreatic Cancer. 


1. There are no good treatments for Pancreatic Cancer a cancer that has killed several high profile people in recent years

including Steve Jobs CEO of Apple,  Alex Trebeck of Jeopardy fame and many others.

2 new people with experience in Biotech and buyouts have been recently added to Oncolytics Biotech’s BOD

2.  Oncolytics Biotech along with Big Pharma company Roche did a 3 patient safety study with the cancer killing virus pelareorep and Roche's CI drug Tecentriq and chemo and all 3/3 patients responded to the treatment with an average tumor shrinkage of 48% at 16 weeks!!! More patients will be added and more data to follow. 

3. More Panceatic cancer patient data will be released at a major medical meeting later this year. We expect this data will have a major effect on the stock price.

4. Oncolytics Biotech also is preparing for a Phase 3 Breast cancer trial with Pfizer after data release in 2023 at a major medical meeting. 

5. Oncolytics Biotech has been around since 1998 has treated over 1000 patients safely with their patented natural cancer killing virus Pelareorep. We believe that the stock has fallen out of favor with investors and brokerages and is poised for a major breakout once the next set of Pancreatic cancer data is released. 



Comments

Post a Comment

Popular posts from this blog

First Stock Pick Oncolytics Biotech

 New Blog starting on 16 September 2022. Plan is to feature ONLY 5 stocks per year, that will have at least a possibility to double in a year. We will be looking for undervalued and turnaround situations with ability to provide good Gains for investors. Please invest at your own risk We are investors with experience,  but as always there are no Guarantees. So it will be easy to follow because we will be only covering a few stocks per year. Our First Stock Pick is Oncolytics Biotech  ONCY on NASDAQ and ONC on Toronto exchange.  Current Price is 1.72 CDN and 1.31 US. We believe that Oncolytics Biotech will be bought by Roche or Pfizer in less than a year and possibly within 6 months or less. A bidding war between the two big Pharmas is  possible. See next message for investment thesis. 
Read more

Our Third Stock Pick Geodrill

 Free stock investing Blog.  Invest at your own risk 19 Sept 2022 Our third Stock pick Geodrill is yet another potential buyout candidate over the next 12 months. GEO .TO or GEODF on OCTQX  Closing Price  $2.50 CDN or 1.90 US 1. Geodrill is a potential takeover target,. The CEO has made it clear he's ready to retire but no buyer yet and CEO is doing an excellent job to continue growing the company and paying a dividend now as well. CEO David Harper started the company with one drill rig and one contract in 1998. 2.  Recent youtube video by Radius Research will give you a lot of info on the company.  https://www.youtube.com/watch?v=43Ofg-_DpPg 3. Geodrill uplisted recently to the 2nd tier OTCQX  making it easier for US investors to purchase this interesting small cap company. It looked like it was going for a nice runup then the market crash happened.  I think this presents a good buying opportunity. 4.  Geodrill is a leading exploration drill...
Read more

July 15 2023 Updates

 Due to an extremely busy life and work schedule. I was unable to continue this Blog. I'm giving it another shot and will try to keep it going.  I had 2 other people helping me but they were unable to contribute as well. So the analysis will be I instead of "we" for the near future anyway. I may try to recruit other help. The idea is to pick 5 stocks in any year period no more, perhaps less. That have the potential to double.  In my stock investing I have seen many stocks double, everyone is focused on multi baggers. To me it seems more prudent to look for doubles and the sell half or all or hold if things look very promising otherwise look for a new opportunity. My focus will be Canadian small cap stocks and  possibility of microcaps as well, but will consider all opportunities. Adding a new rating system to each stock as well. 1 to 5, 1 being one I consider less risky and 5 being highest risk.  ONC.TO  my first feature pick has more than doubled since las...
Read more